4d Pharma Share Discussion Threads

[someuwin] 27/5/2015 15:51

Google Ventures: These eight life sciences techs are the most promising – and worthy of investment

Google Ventures just laid its cards on the table over which life sciences technologies it thinks have the most investment appeal. Artificial intelligence, stem cell science and understanding the human microbiome hit the highlight reel. Here’s why:

6. Understanding the microbiome

Maris is excited about understanding the delicate interplay of the bacteria in our microbiome – after all, some researchers call this bacterial ecosystem the “forgotten organ.” Fecal transplants and “reprogramming” naturally occurring bacteria for cancer treatment are just two examples of how harnessing the microbiome could have massive therapeutic potential.

[yeomdad] 24/5/2015 20:51

DDDD has had an amazing rise which could keep on going - not in it myself but hoping some news from OPTI this week might mean a similar % rise over there. Well done to all DDDD holders.

[modform] 24/5/2015 20:47

Although I have taken my original investment out, the remainder has multi bagged. I think ever day I should sell but the share price keeps rising, so I plan to ride it for a little bit longer, I hope greed will not make me regret.

[blueball] 22/5/2015 18:34

Look at the finish this is half way to £12 in a short time.

[talkingtrades] 22/5/2015 10:42

Amazed at this stock...Just hope it spills over to OPTI

[someuwin] 22/5/2015 10:19

...Anything is possible here.

Especially with Woodford increasing to 19.1% holding this month.

[blueball] 22/5/2015 08:50

£15 coming soon.

[someuwin] 22/5/2015 08:05

Moving up again.

[someuwin] 21/5/2015 15:51

Stock tightly held.

All buys are pushing it up.

[someuwin] 21/5/2015 12:28

£10+ today

[someuwin] 21/5/2015 11:23

I am convinced DDDD is in the process of being bought out. Very soon the buyer will come out with a full offer - imo.

At that point the spotlight will fall on OPTI as the only other microbiome player on the london market.

[someuwin] 20/5/2015 07:11

20 May 2015

4D pharma plc

(the "Company" or "4D")

Research Update on Clinical Development

4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, today provides the following research update on its Clinical Development Programmes.

The Company currently has two programmes progressing towards the clinic, Blautix, for the treatment of Irritable Bowel Syndrome ("IBS"), and Thetanix, for the treatment of Paediatric Crohn's Disease.

The Board of the Company is pleased to report that a dossier for Blautix has been submitted to Swissmedic (Swiss Agency for Therapeutic Products) and the EKNZ (Swiss ethics committee) in relation to a first in man study to be carried out in healthy volunteers and individuals exhibiting symptoms of IBS.

Thetanix also continues to progress towards a first in man study, to be carried out in Paediatric Crohn's patients. Following a development programme to further optimise the Thetanix drug product, it is now anticipated that this trial will commence in H2 2015.

Dr. Alex Stevenson, 4D's Chief Scientific Officer, commented "4D is at the forefront of the development of live biotherapeutics, a new class of drug designed to treat the underlying causes of disease rather than just the symptoms. A critical component of making live biotherapeutics a reality is the ability to rapidly translate candidates identified in the laboratory into pharmaceutical grade products that can be administered to patients. Over the last few months we have made tremendous progress in establishing a methodology that allows us to do just that. With Blautix and Thetanix approaching the clinic, we are applying this same methodology to our pipeline of novel live biotherapeutic treatments for additional indications, such as asthma and rheumatoid arthritis, in line with our goal of developing ground breaking treatments for a wide range of important diseases".

[someuwin] 15/5/2015 11:15

...Still all buys.

[someuwin] 14/5/2015 11:04

All buys so far today.

Should move up again soon.

[blueball] 13/5/2015 12:25

I reckon 1000p a share very soon.

[talkingtrades] 13/5/2015 11:54

Guys also have a look at OPTI. Same sector as 4D but only valued at £26 million with commercial deals on the way.But well done with DDDD wish I'd seen it earlier.

[tjbird] 13/5/2015 11:52

Woodford also bought 15% of UTW

[someuwin] 13/5/2015 11:49

Can't get a live price for just £1k worth.

This will be moving higher imo.

[someuwin] 13/5/2015 11:29

Over £8 now.

[someuwin] 07/5/2015 07:16

Woodford increases holding again - now 19.1%.

[plasybryn] 26/4/2015 17:06

Thanks someuwin. I have already bought into OPTI where the valuation seems far less hyped.
I guess it is all about leaps of faith!